Sherbrooke, Canada

Luc Ouellet

This inventor holds 13 USPTO granted patents, plus 2 CIPO patents and 5 EPO patents. Top assignees: Tranzyme Pharma Inc., Ocera Therapeutics, Inc.. Active years: 2007-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luc Ouellet. Retrieved from https://idiyas.com/inventor/luc-ouellet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 30.8


 

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 59(Granted Patents)


Location History:

  • Québec, CA (2009 - 2013)
  • Sherbrooke, CA (2007 - 2018)

Company Filing History:


Years Active: 2007-2018

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Luc Ouellet - Inventor from Sherbrooke, CA

Introduction: Luc Ouellet is a renowned inventor based in Sherbrooke, Canada, known for his innovative contributions to various fields.

Latest Patents: Luc Ouellet holds several patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced manufacturing processes.

Career Highlights: With a career spanning over two decades, Luc Ouellet has been instrumental in developing cutting-edge solutions that have significantly impacted industries such as clean energy, environmental conservation, and precision engineering.

Collaborations: Throughout his career, Luc Ouellet has collaborated with leading research institutions, universities, and multinational corporations to bring his inventions to market and drive positive change on a global scale.

Conclusion: Luc Ouellet's passion for innovation and commitment to creating a more sustainable future continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…